Ensign Group
ENSIGN GROUP, INC
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$5.1B
Operating marginCalculated
8.4%
Net assets to total assetsCalculated
40.9%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★☆☆position among all companies
8.4%
Growth (revenue, 4-year average)
★★★★★position among all companies
17.8%
Capital efficiency
★★★★☆position among all companies
15.4%
Revenue and profit
Performance, financial position and capital allocation
Ensign Group
Recent performance trends
Ensign Group
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$2.6 billion | US$3.0 billion | US$3.7 billion | US$4.3 billion | US$5.1 billion |
| Operating income | US$0.3 billion | US$0.3 billion | US$0.3 billion | US$0.4 billion | US$0.4 billion |
| Net income | US$0.2 billion | US$0.2 billion | US$0.2 billion | US$0.3 billion | US$0.3 billion |
| Total assets | US$2.9 billion | US$3.5 billion | US$4.2 billion | US$4.7 billion | US$5.5 billion |
| Shareholders' equity | US$1.0 billion | US$1.2 billion | US$1.5 billion | US$1.8 billion | US$2.2 billion |
| Net cash provided by (used in) operating activities | US$0.3 billion | US$0.3 billion | US$0.4 billion | US$0.3 billion | US$0.6 billion |
| Net cash provided by (used in) investing activities | US$-0.2 billion | US$-0.2 billion | US$-0.2 billion | US$-0.4 billion | US$-0.5 billion |
| Net cash provided by (used in) financing activities | US$-76.14 million | US$-32.26 million | US$-0.61 million | US$-2.16 million | US$-11.81 million |
| Cash and cash equivalents | US$0.3 billion | US$0.3 billion | US$0.5 billion | US$0.5 billion | US$0.5 billion |
Revenue scale in the same industry
Ensign Group
Health services: 20 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 HCA Healthcare US$75.6B
- 2 Tenet Healthcare US$21.3B
- 3 Universal Health Services US$17.4B
- … 9 companies
- 13 Select Medical Holdings US$5.5B
- 14 PACS Group US$5.3B
- 15 Ensign GroupThis company US$5.1B
- 16 Acadia Healthcare Company US$3.3B
- 17 Surgery Partners US$3.3B
- … 3 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Cash and cash equivalents | US$0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-11.81 million | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.1 billion | Consolidated | Disclosed |
| Dividends paid | US$14.41 million | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$2.2 billion | Consolidated | Disclosed |
| Non-controlling interests | US$3.10 million | Consolidated | Disclosed |
| Net assets | US$2.2 billion | Consolidated | Disclosed |
| Net sales | US$5.1 billion | Consolidated | Disclosed |
| Operating income | US$0.4 billion | Consolidated | Disclosed |
| Net income | US$0.3 billion | Consolidated | Disclosed |
| Total assets | US$5.5 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$20.00 million | Consolidated | Disclosed |
| Operating margin | 8.4% | Consolidated | Calculated |
| Net assets to total assets | 40.9% | Consolidated | Calculated |
| Net margin | 6.8% | Consolidated | Calculated |
| Return on equity | 15.4% | Consolidated | Calculated |